The production of biological medicines requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The proposed solution combines modern clean infrastructure and research-based processes to deliver sterile and scalable biotechnological solutions in different forms of dosage. Systematic quality management and strict regulatory compliance ensure a result that supports market entry and patient safety.

For whom

Service is suitable for pharmaceutical companies, biotechnology start-ups, clinical trial partners and contrast manufacturers looking for a reliable partner in biotechnology production and sterile pharmaceutical production for projects. A separate value is offered to those who need production in different forms of dosing - both liquid, lyophilisate, syringe, vials and indirect routes of administration can be considered.

What is offered

• <<<Scalibrated production solution: processes that scale from the laboratory to the level of clinical and commercial production.
li>Process development and technical transfer: process optimization, documentation and smooth transition < > <live.</live and regulatory processes, lyophilisation and strict purity standards. < < < < < < < :

The implementation of biological and biotechnological solutions above the average provides assurance that production meets both scientific and regulatory expectations. Contact us to discuss specific needs and formulate a scalable production plan that supports commercial objectives.